Literature DB >> 15312994

Bidirectional on/off switch for controlled targeting of proteins to subcellular compartments.

C Kanwal1, S Mu, S E Kern, C S Lim.   

Abstract

A regulatable fusion protein was constructed for controlling the localization of plasmid products. A ligand-inducible nuclear localization signal, nuclear export signal (NES) and a truncated form of the ligand binding domain of the progesterone receptor were attached to the desired protein. Enhanced green fluorescent protein (EGFP) was used as a model protein and its trafficking between the nucleus and cytoplasm was studied using fluorescence microscopy in response to the ligand, mifepristone. It was found that the protein trafficking into the nucleus was dose dependent with ligand concentration. Increasing the ligand dose from 1 to 100 nM enhanced import and reduced the rate of export of the fusion protein from the nucleus to the cytoplasm. This study demonstrates the feasibility of using an export signal and a ligand-inducible nuclear import signal as a bi-directional on/off switch with potential use for controlled targeting of therapeutic proteins to subcellular compartments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312994     DOI: 10.1016/j.jconrel.2004.05.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain.

Authors:  Andrew S Dixon; Carol S Lim
Journal:  Biotechniques       Date:  2010-07       Impact factor: 1.993

Review 2.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

3.  Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domain.

Authors:  Mudit Kakar; James R Davis; Steve E Kern; Carol S Lim
Journal:  J Control Release       Date:  2007-05-03       Impact factor: 9.776

4.  Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switch.

Authors:  Mudit Kakar; Amy B Cadwallader; James R Davis; Carol S Lim
Journal:  Pharm Res       Date:  2007-06-13       Impact factor: 4.200

5.  Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs.

Authors:  Andrew S Dixon; Jonathan E Constance; Tomoyuki Tanaka; Terence H Rabbitts; Carol S Lim
Journal:  Pharm Res       Date:  2011-12-20       Impact factor: 4.200

6.  Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle.

Authors:  Anthony H Taylor; Muna Guzail; May Wahab; John R Thompson; Farook Al-Azzawi
Journal:  Histochem Cell Biol       Date:  2005-05-12       Impact factor: 4.304

7.  Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation.

Authors:  Amy B Cadwallader; Douglas E Rollins; Carol S Lim
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 8.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

9.  Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.

Authors:  James R Davis; Mohanad Mossalam; Carol S Lim
Journal:  Mol Pharm       Date:  2013-03-01       Impact factor: 4.939

10.  Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ.

Authors:  Nune Darbinian; Yuri Popov; Kamel Khalili; Shohreh Amini
Journal:  Antiviral Res       Date:  2007-12-26       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.